Prediction of disease severity in neuromyelitis optica by the levels of IL-6 produced during remission phase. Barros PO, Cassano T, Hygino J, Ferreira TB, Centurião N, Kasahara TM, Andrade RM, Linhares UC, Andrade AFB, Vasconcelos C CF, et al. Clin Exp Immunol. 2015 Oct 16. PMID: 26472479. Abstract CommentRecommendBookmarkWatch